~~<i id='8F3AEB31A9'><strike id='8F3AEB31A9'><tt id='8F3AEB31A9'><pre id='8F3AEB31A9'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

author：knowledge 2025-09-30 12:37:15 Page View：1

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： A letter from the executive editor: STAT UnitedHealth investigation
Next article： Medicare proposal to cover medical devices draws a mixed reaction

comprehensive

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

CVS, Rite Aid closures threaten to worsen pharmacy deserts

ScottOlson/GettyImagesPharmacieswereonceabundantintheSouthSideofChicago.Now,residentslivinginthemajo

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

After Optum profits sink, UnitedHealth makes changes

TheprofitmarginatOptumHealthisatthelowestinadecade.CourtesyUnitedJustweeksafterthedivisionofUnitedHe